Enlivex Ltd.

ENLV · Finance Services

Save to watchlist Sign in to save

Latest available SEC filing: SCHEDULE 13G ·

Latest disclosures

All company filings

Institutional holders by security

Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.

  • ENLV · M4130Y106 - Class A common stock
  • ENLV · M4130Y171 - Ordinary Shares, par value NIS 6.00 per share
Company details and SEC sources

CIK 0001596812 · SEC filing index. Filing dates describe disclosures, not live market data.

Listed symbols
ENLV on Nasdaq
At a glance Names, identifiers, and filing context for this profile. 2 identity fields
SEC industry group
Finance Services (Office of Finance Or Office of Crypto Assets)
Business address
37 Dereh Menachem Begin St., 15 Th Floor, Tel Aviv
EDGAR profile Static EDGAR fields kept behind disclosure so the main profile stays readable. 3 profile fields available
Incorporated in
Israel
Fiscal year end
31 December
Former names on EDGAR
Enlivex Therapeutics Ltd. (to 10 Feb 2026), Bioblast Pharma Ltd. (to 18 Mar 2019), BIO BLAST PHARMA LTD. (to 12 Sep 2016)
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .